Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children whether or not they have another inflammatory condition, such as asthma, allergic rhinitis or food allergies.
Dupilumab improves symptoms of atopic dermatitis in children with co-existing conditions
- Thread starter Educator
- Start date